Balyasny Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-335	Closed	-$7.08K	–	2319
2023 Q2	$7.08K	Buy	+335	New	+$7.08K	﹤0.01%	1791
2015 Q3	–	Sell	-51	Closed	-$29K	–	1232
2015 Q2	$29K	Buy	+51	New	+$29K	﹤0.01%	880